Fertility challenges for women with sickle cell disease

Djamila L Ghafuri1, Sarah-Jo Stimpson1, Melissa E Day1

  • 1a Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt-Meharry-Matthew Walker Center for Excellence in Sickle Cell Disease , Vanderbilt University Medical Center , Nashville , TN , USA.

Expert Review of Hematology
|September 12, 2017
PubMed

Insights

Women with sickle cell disease (SCD) face unique reproductive health challenges, including infertility and premature menopause. Early consultation with fertility specialists is crucial for family planning and fertility preservation before treatments like HSCT.

Area of Science:

  • Reproductive Medicine
  • Hematology
  • Genetics

Background:

  • Sickle cell disease (SCD) is a common monogenic blood disorder affecting over 300,000 newborns annually.
  • Reproductive challenges in women with SCD are significant, impacting quality of life.
  • Evidence-based strategies for managing infertility and enhancing fecundity in women with SCD are lacking.

Purpose of the Study:

  • To review risk factors for infertility, low fecundity, and premature menopause in women with SCD.
  • To highlight unique pathophysiological mechanisms contributing to reproductive dysfunction in SCD.
  • To provide expert commentary on management and fertility preservation strategies.

Main Methods:

  • Literature review summarizing known risk factors and pathophysiological mechanisms.
  • Expert commentary on clinical management and recommendations.

Main Results:

  • Women with SCD experience infertility due to chronic inflammation, oxidative stress, hemochromatosis, and ovarian sickling.
  • Hydroxyurea therapy requires contraception and discontinuation for family planning due to teratogenicity.
  • Hematopoietic stem cell transplantation (HSCT) conditioning regimens can cause infertility and premature ovarian failure.

Conclusions:

  • Women with SCD have specific risk factors impacting fertility.
  • Contraception and careful management of hydroxyurea are essential.
  • Fertility preservation and surrogacy options should be discussed before HSCT or gene therapy, with referral to a reproductive endocrinologist recommended.
Abstract

Related Concept Videos

Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
4.9K
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
123.9K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.4K
Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
609
Meiosis II01:57

Meiosis II

Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
209.3K
Meiosis vs. Mitosis02:57

Meiosis vs. Mitosis

Cell division is necessary for growth and reproduction in organisms. Mitosis aids cell growth and development by dividing somatic cells. In contrast, meiosis causes the division of germ cells and plays an essential role in sexual reproduction. Due to their unique functional requirements, mitosis and meiosis differ from each other in multiple aspects.
Before the start of mitosis and meiosis I, the cell synthesizes DNA, resulting in two homologous copies of each chromosome. DNA synthesis is...
71.7K